000 | 01628 a2200409 4500 | ||
---|---|---|---|
005 | 20250513134943.0 | ||
264 | 0 | _c19980331 | |
008 | 199803s 0 0 eng d | ||
022 | _a0091-3057 | ||
024 | 7 |
_a10.1016/s0091-3057(97)00439-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPérez, C | |
245 | 0 | 0 |
_aDevazepide, a CCK(A) antagonist, attenuates the satiating but not the preference conditioning effects of intestinal carbohydrate infusions in rats. _h[electronic resource] |
260 |
_bPharmacology, biochemistry, and behavior _cFeb 1998 |
||
300 |
_a451-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzodiazepinones _xadministration & dosage |
650 | 0 | 4 |
_aConditioning, Psychological _xdrug effects |
650 | 0 | 4 | _aDevazepide |
650 | 0 | 4 |
_aDietary Carbohydrates _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFood Preferences _xdrug effects |
650 | 0 | 4 |
_aGlucans _xpharmacology |
650 | 0 | 4 |
_aHormone Antagonists _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 | _aIntubation, Gastrointestinal |
650 | 0 | 4 |
_aMaltose _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aReceptor, Cholecystokinin A |
650 | 0 | 4 |
_aReceptors, Cholecystokinin _xantagonists & inhibitors |
650 | 0 | 4 |
_aSatiety Response _xdrug effects |
700 | 1 | _aLucas, F | |
700 | 1 | _aSclafani, A | |
773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 59 _gno. 2 _gp. 451-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0091-3057(97)00439-5 _zAvailable from publisher's website |
999 |
_c9445871 _d9445871 |